Frank X. Leonard, Chief Executive Officer at NovoCure Ltd (NVCR), sold 16,966 shares at $13.66 ($231K) on 2026-02-27, disclosed to the SEC on 2026-03-03.
Seasonal sale ($231k) by Chief Executive Officer — this insider has traded NVCR in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.66 | 9,734 | $133K | 57.7% |
| 2 | $13.49 | 7,232 | $98K | 42.3% |
| Total | $13.59 avg | 16,966 | $231K | 100% |
| Filing → |
| NVCR | SELL | 2025-06-04 | $1.0M | — | Filing → |
| NVCR | SELL | 2025-03-04 | $47K | — | Filing → |
| NVCR | SELL | 2025-03-03 | $552K | — | Filing → |